Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted Treatment

Current Fungal Infection Reports - United States
doi 10.1007/s12281-008-0010-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Strategies in Prevention of Invasive Pulmonary Aspergillosis in Immunosuppressed or Neutropenic Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Diagnosis and Treatment of Invasive Pulmonary Aspergillosis in Neutropenic Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Cost-Effectiveness Analysis of Isavuconazole Versus Voriconazole for the Treatment of Patients With Possible Invasive Aspergillosis in Sweden

BMC Infectious Diseases
Infectious Diseases
2019English

Cost Analysis of Voriconazole Versus Liposomal Amphotericin B and Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients in Lebanon

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Cost-Effectiveness of Posaconazole Versus Fluconazole/ Itraconazole in the Prevention of Invasive Fungal Infections Among High-Risk Neutropenic Patients in Singapore

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost Analysis of Voriconazole Versus Liposomal Amphotericin B and Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients in Saudi Arabia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients.

BMJ
1991English

Diagnosis and Treatment of Invasive Pulmonary Aspergillosis in ICU

Nihon Shuchu Chiryo Igakukai zasshi
2008English

Invasive Diagnostics and Surgical Treatment of Pulmonary Aspergillosis

Ukrainian Pulmonology Journal
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy